Episode 27 - MG Podcast: Emerging Insights from AAN 2026

Clinical care for myasthenia gravis is entering a period of meaningful progress, with growing opportunities to improve how the disease is diagnosed, assessed, and treated. Increased awareness of disease heterogeneity and the expanding use of standardized severity assessments are helping clinicians better define disease burden and guide management decisions.In this 20-minute podcast episode, Dr. James Howard Jr. provides comprehensive coverage of key MG presentations, scientific symposia, posters, and abstracts presented at AAN 2026.Launch/Release Date: April 23, 2026Activity Expiration Date: March 31, 2027FACULTYJames F. Howard, Jr., MD, FAANProfessor of Neurology, Medicine & Allied HealthDirector, Myasthenia Gravis Clinical Trials and Translational Research ProgramThe University of North Carolina at Chapel HillThis podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.